You just read:

AFYX Therapeutics Announces Completion of Enrollment in Phase 1 Clinical Trial of the Rivelin Patch in Patients with Vulvar Lichen Sclerosus

News provided by

AFYX Therapeutics

Dec 04, 2018, 09:01 ET